Investor Group to Vote AGAINST Sesen Bio Merger with Carisma

 Proposes Alternative to the Merger That Would Deliver Superior Value for Sesen Bio’s Stockholders

Questions the Sesen Bio Board’s Resistance to Obtaining a New Fairness Opinion for Carisma Now That Comparable Companies Have Declined 30%-60% Since the Merger Announcement

https://finance.yahoo.com/news/investor-group-reiterates-intent-vote-130000302.html